Literature DB >> 9194899

p53 accumulation and apoptosis in embolized meningiomas.

S Nakasu1, M Nakajima, T Nakazawa, Y Nakasu, J Handa.   

Abstract

Preoperative embolization of meningiomas is performed to decrease blood loss at surgery. While it is also expected to reduce tumor recurrence by producing necrosis at the site of dural attachment, very little has been described about what happens to the non-necrotic tumor cells. We investigated how the proliferative activities of meningiomas were modified after embolization. In nine meningiomas which were embolized preoperatively, proliferative potentials and expression of cell cycle inhibitors were assessed immunohistochemically using MIB-1, anti-53 (DO-1 and DO-7), and anti-p21 (WAF1/CIP1) monoclonal antibodies. To determine whether a cell underwent apoptotic death besides necrosis, we applied the terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling method. Results were compared with control meningiomas without embolization. MIB-1 positive cells often gathered in perinecrotic areas, although the mean MIB-1 staining index of the embolized meningiomas was not significantly different from the control. p53 and its downstream effector p21 accumulated mainly in the perinecrotic areas in eight of the nine embolized meningiomas. Apoptosis was also observed in the concomitant areas. Double staining for both MIB-1 and p21 frequently showed positive cells for both antibodies. The accumulation of MIB-1 positive cells in the embolized meningiomas may not be a sign of fast growth or malignancy, but it may implicate arrest of cell cycle by the p21. This study indicates that embolized meningiomas exhibit not only necrosis but also apoptosis and cell cycle arrest. The latter effects appear to be at least partly p53 dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194899     DOI: 10.1007/s004010050657

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  4 in total

1.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Embolized meningiomas: risk of overgrading and neo-angiogenesis.

Authors:  Valeria Barresi; Giovanni Branca; Francesca Granata; Concetta Alafaci; Maria Caffo; Giovanni Tuccari
Journal:  J Neurooncol       Date:  2013-03-18       Impact factor: 4.130

Review 3.  Pathology and molecular genetics of meningioma: recent advances.

Authors:  Makoto Shibuya
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

4.  NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells.

Authors:  Rama P Kotipatruni; Xuan Ren; Dinesh Thotala; Jerry J Jaboin
Journal:  Oncotarget       Date:  2015-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.